LIFEVANTAGE CORP (LFVN:OTC BB): Stock Quote & Company Profile - Businessweek
lifevantage corp (LFVN:OTC BB)
As of 2:43 PM 03/7/12 All times are local (Market data is delayed by at least 15 minutes).
lifevantage corp (LFVN) Snapshot
Open $2.27 | Previous Close $2.27 | |
Day High $2.44 | Day Low $2.27 | |
52 Week High 03/7/12 - $2.44 | 52 Week Low 03/15/11 - $0.68 | |
Market Cap 239.1M | Average Volume 10 Days 665.7K | |
EPS TTM $-0.23 | Shares Outstanding 100.5M | |
LFVN Does Not Pay Dividends | P/E TM -- |
Related News
No related news articles were found.
lifevantage corp (LFVN)Related Businessweek News
No Related Businessweek News Foundlifevantage corp (LFVN) Details
LifeVantage Corporation, a science-based company, engages in the identification, research, development, manufacture, and distribution of nutraceutical dietary supplements in the United States. The company offers Protandim, a dietary supplement that combats oxidative stress by enhancing the body’s natural antioxidant protection at the genetic level; and TrueScience, an anti-aging skin care product. It sells its products through a network of independent distributors, as well as preferred, retail, and direct customers in the United States, Japan, Mexico, and Canada. The company was founded in 2003 and is based in San Diego, California.lifevantage corp (LFVN) Top Compensated Officers
Chief Executive Officer, President, Director ...
Age: 48
Total Annual Compensation: $201.3K
Chief Financial Officer, Principal Accounting...
Age: 40
Total Annual Compensation: $200.0K
Chief Operating Officer, Executive Vice Presi...
Age: 57
Total Annual Compensation: $216.0K
President of Network Marketing Operations, Di...
Age: 48
Total Annual Compensation: $439.4K
Chief Scientific Officer and Member of Strate...
Age: 66
Total Annual Compensation: $447.4K
Compensation as of Fiscal Year 2011.
lifevantage corp (LFVN) Key Developments
Lifevantage Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2011; Revises Earnings Guidance for the Fiscal Year 2012
Feb 14 12
Lifevantage Corporation reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2011. For the quarter, the company has reported net sales of $25,284,058 compared to $7,460,089 for the same period a year ago. Operating income was $4,281,874 compared to $608,982 for the same period a year ago. Net income before income taxes was $7,449,580 compared to $5,542,624 for the same period a year ago. Net income was $8,758,639 compared to $5,447,624 for the same period a year ago. Net income per share, diluted was $0.05 compared to $0.00 for the same period a year ago. The company generated $4.7 million of cash flow from operations in the second quarter of fiscal 2012, compared to $0.5 million in the second quarter of fiscal 2011. For the six months, the company has reported net sales of $45,367,357 compared to $13,903,438 for the same period a year ago. Operating income was $7,711,667 compared to $953,751 for the same period a year ago. Net income before income taxes was $11,645,347 compared to $6,257,817 for the same period a year ago. Net income was $12,482,806 compared to $6,162,817 for the same period a year ago. Net income per share, diluted was $0.07 compared to loss of $0.01 for the same period a year ago. The company is raising its full year guidance for fiscal 2012. The company expects to generate revenue for the fiscal year in a range of $105 million to $115 million, compared to the previous range of $95 million to $105 million. Further, the company expects to generate operating income for the fiscal year in a range of $13.7 million to $17.3 million, and an operating margin of 13% to 15%. The previous range of operating income was $11.4 million to $14.7 million, and an operating margin of 12% to 14%.
